EDEN PRAIRIE, Minn. , Oct. 01, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced that it has submitted an application to the FDA requesting for 510(k) clearance of the Aquadex FlexFlow system to include pediatric patients who weigh 20kg or more.
EDEN PRAIRIE, Minn. , Sept. 24, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced the publication of a multi-center, retrospective study in the Clinical Journal of the American Society of Nephrology 1 evaluating the use of hemofiltration and ultrafiltration therapy with the
EDEN PRAIRIE, Minn. , Sept. 19, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Claudia Napal Drayton , the company’s CFO, will be presenting and meeting with investors at the 2019 Landenburg Thalmann’s 2019 Healthcare Conference on September 24, 2019 at 4:00 PM ET
EDEN PRAIRIE, Minn. , Sept. 17, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announced today that it will host a conference call and webcast at 1:00 PM ET on Wednesday, September 25, 2019 to discuss the results of a multicenter, retrospective study involving pediatric patients who
EDEN PRAIRIE, Minn. , Sept. 10, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced it would be exhibiting at the 23 rd Annual Scientific Meeting of the Heart Failure Society of America from September 14-16, 2019 . The conference is being held at the Pennsylvania Convention
EDEN PRAIRIE, Minn. , Sept. 06, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on September 3, 2019 , the independent directors approved four equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to four individuals entering
EDEN PRAIRIE, Minn. , Sept. 04, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Maria Rosa Costanzo , M.D. has been appointed to the Company's Board of Directors. Dr. Costanzo is the medical director, Heart Failure Research , at Advocate Heart Institute , and the
EDEN PRAIRIE, Minn. , Aug. 16, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on August 15, 2019 , the independent directors approved nine equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to nine individuals entering into
EDEN PRAIRIE, Minn. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (Nasdaq: CHFS) announced today the publication of a study in Circulation Heart Failure 1 highlighting the benefits of decongestion outweigh concerns from previous studies that showed a rise in creatinine levels or tubular
EDEN PRAIRIE, Minn. , Aug. 06, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven alternative to diuretics for the treatment of fluid overload, announced today its results for the second